HCK: Tyrosine-protein kinase HCK
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Non-receptor tyrosine-protein kinase found in hematopoietic cells that transmits signals from cell surface receptors and plays an important role in the regulation of innate immune responses, including neutrophil, monocyte, macrophage and mast cell functions, phagocytosis, cell survival and proliferation, cell adhesion and migration.
- Drugs that act on it: 1
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Drug | US approval | Mechanism | Action | Warnings |
|---|---|---|---|---|
| Bosutinib | Approved | Tyrosine-protein kinase HCK inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Neoplasm
- 0.49
- Breast cancer
- 0.43
- Neurodegenerative disease
- 0.42
- Autoinflammation with pulmonary and cutaneous vasculitis
- 0.40
- HIV infectious disease
- 0.37
- Myeloid leukemia
- 0.37
- Hypertensive disorder
- 0.35
Genes and Related Targets
Complexes and families that share a gene with this target- Genes
- HCK
- Related
- SRC
Drugs and mechanisms are from ChEMBL CHEMBL3234 (CC BY-SA 3.0). Gene name, function (UniProt P08631, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets